SCHEMBL16769423

SCHEMBL16769423

CCCCCCc1cc(CCCCCC)cc(-c2nc(-c3ccc(-c4c(C)cc(C)cc4C)cn3)nc(-c3ccc(-c4c(C)cc(C)cc4C)cn3)n2)c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 8/20 0.44
SMN1; SMN2 Q16637 7/20 0.44
NPC1 O15118 6/20 0.44
MAPT P10636 6/20 0.44
STAT3 P40763 1/20 0.44
ATM Q13315 1/20 0.44
NFKB1 P19838 3/20 0.42
NFKB2 Q00653 3/20 0.42
RELA Q04206 3/20 0.42
L3MBTL1 Q9Y468 2/20 0.41
CASP3 P42574 2/20 0.41
SENP8 Q96LD8 2/20 0.41
SENP7 Q9BQF6 2/20 0.41
SENP6 Q9GZR1 2/20 0.41
ALDH1A1 P00352 4/20 0.40
KDM4E B2RXH2 3/20 0.40
HPGD P15428 3/20 0.40
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
USP2 O75604 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16769418 0.93 RAB9A (0.49) RAB9ASMN1; SMN2NPC1MAPTSTAT3
SCHEMBL16769428 0.93 RAB9A (0.49) RAB9ASMN1; SMN2NPC1MAPTSTAT3
SCHEMBL16769411 0.88 RAB9A (0.45) RAB9ASMN1; SMN2NPC1MAPTSTAT3
SCHEMBL16769422 0.87 MEN1 (0.43) RAB9ASMN1; SMN2MAPTALDH1A1KDM4E
SCHEMBL16769419 0.86 RAB9A (0.40) RAB9ASMN1; SMN2NPC1MAPTSTAT3
SCHEMBL16769426 0.82 MAPT (0.53) RAB9ASMN1; SMN2NPC1MAPTSTAT3
SCHEMBL16769420 0.82 MAPT (0.53) RAB9ASMN1; SMN2NPC1MAPTSTAT3
SCHEMBL16769392 0.81 RAB9A (0.40) RAB9ASMN1; SMN2NPC1MAPTSTAT3
SCHEMBL16769412 0.81 ALDH1A1 (0.50) RAB9ASMN1; SMN2MAPTALDH1A1KDM4E
SCHEMBL12622323 0.80 CCR1 (0.39) RAB9ANPC1MAPTKDM4EMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9853218-B2 High-molecular compound and light-emitting element using same SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-12-26 US disclosed
US-20150155495-A1 HIGH-MOLECULAR COMPOUND AND LIGHT-EMITTING ELEMENT USING SAME SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2015-06-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150155495-A1 HIGH-MOLECULAR COMPOUND AND LIGHT-EMITTING ELEMENT USING SAME ARL1, CCNL2, CRKL RAB9A 825/4885SMN1; SMN2 3233/4885NPC1 4029/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.